knowledge -WSS

knowledge

author：leisure time 2025-10-01 05:38:51 - browse：394

Robert F. Kennedy Jr. arrives in the lobby of Trump Tower in New York for a meeting with President-elect Donald Trump. Evan Vucci/AP

WASHINGTON — Outspoken vaccine critic Robert Kennedy Jr. said Tuesday that he had accepted a position in Donald Trump’s administration as chair of a panel on vaccine safety and scientific integrity, in what would be the clearest sign yet of the president-elect’s suspicions about vaccines.

Kennedy’s remarks followed his meeting with the president-elect at Trump Tower and immediately sparked outrage from scientists, pediatricians, and public health experts, who fear the incoming administration could give legitimacy to skeptics of childhood immunizations despite a huge body of scientific research demonstrating that vaccines are safe. Many of those skeptics believe vaccines are a cause of autism.

Hours later, Trump spokeswoman Hope Hicks said in a statement that the president-elect was “exploring the possibility of forming a commission on Autism,” but said “no decisions have been made at this time.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： RSV shot was 90% effective at preventing hospitalizations in kids

hotspot

explore

knowledge

WSS

IVF, abortion rights issues kick off Biden’s State of the Union

Nick Jonas talks about managing diabetes along with his career

Air quality improving but still lags in Black, Hispanic communities

Nick Jonas talks about managing diabetes along with his career

First medicine developed to treat MASH expected to be approved soon

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

leisure time

knowledge

focus

The high cost of giving birth even with insurance

Eight reasons why you should get an updated Covid vaccine

In age of alternative facts, a scholarly course on calling out crap

Akero's treatment for NASH falls short in cirrhosis study

At least 13 dead in Texas as scorching temps continue

First medicine developed to treat MASH expected to be approved soon

23andMe had bad news about my health. I wish a person had delivered it

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

entertainment

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

STAT Readout Newsletter: Today in biotech, life science news

STAT Readout: Today's biotech news includes Sana and Amylyx

RSV shot was 90% effective at preventing hospitalizations in kids

Humana CEO Bruce Broussard to step down in 2024

Medicare to cover more brain scans related to Alzheimer’s drugs

hotspot

explore

knowledge

explore